Loading... Please wait... Loading... Please wait...
ESTIMATED
04/09/2024
04/09/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2024 | 0 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2024 | 0 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2024 | 0 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Mainz Biomed B.V. last posted its earnings results on Tuesday, April 9th, 2024. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.32 by $0.08. The company had revenue of 214,761 for the quarter and had revenue of 895,479 for the year. Mainz Biomed B.V. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -0.27. Mainz Biomed B.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/08/2024 | Q4 2023 | -$0.32 | -$0.24 | 0.08 | $253,332 | $214,761 | 09/29/2023 | Q3 2023 | -$0.39 | $333,333 | $181,669 | 06/30/2023 | Q2 2023 | -$0.55 | $283,333 | $248,945 | 03/31/2023 | Q1 2023 | -$0.45 | $266,667 | $250,104 | 04/07/2023 | Q4 2022 | -$0.58 | $278,500 | $193,281 | 09/29/2022 | Q3 2022 | -$0.39 | $96,791 | 06/29/2022 | Q2 2022 | -$0.50 | $139,240 | 03/30/2022 | Q1 2022 | -$0.42 | $100,565 | 05/02/2022 | Q4 2021 | -$1.30 | $160,037 | 09/29/2021 | Q3 2021 | -$0.41 | $144,337 | 06/29/2021 | Q2 2021 | -$0.02 | $417,311 | 03/30/2021 | Q1 2021 | -$0.00 | $144,337 | 12/30/2020 | Q4 2020 | -$0.01 | $123,391 | 09/29/2020 | Q3 2020 | -$0.01 | $123,391 | 06/29/2020 | Q2 2020 | -$0.01 | $123,391 | 03/30/2020 | Q1 2020 | -$0.01 | $123,391 | 12/30/2019 | Q4 2019 | -$0.02 | $70,348 | 09/29/2019 | Q3 2019 | -$0.02 | $70,348 | 06/29/2019 | Q2 2019 | -$0.02 | $70,348 | 03/30/2019 | Q1 2019 | -$0.02 | $70,348 |
|---|
A. Mainz Biomed B.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. In the previous quarter, Mainz Biomed B.V. (NASDAQ:MYNZ) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.32 by $0.08.
A. The conference call for Mainz Biomed B.V.'s latest earnings report can be listened to online.
A. The conference call transcript for Mainz Biomed B.V.'s latest earnings report can be read online.
A. Mainz Biomed B.V. (NASDAQ:MYNZ) has a recorded annual revenue of $895,479.
A. Mainz Biomed B.V. (NASDAQ:MYNZ) has a recorded net income of $895,479. Mainz Biomed B.V. has generated $-1.62 earnings per share over the last four quarters.
A. Mainz Biomed B.V. (NASDAQ:MYNZ) has a price-to-earnings ratio of -0.27 and price/earnings-to-growth ratio is -0.01.
